Trial intelligence / Profile preview

Melatonin Supports Non Surgical Periodontal Treatment in Patients With Type 2 Diabetes and Periodontitis

NCT05870358Phase 4Completed

Start
Feb 2021
Primary completion
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of melatonin in periodontitis (2 arms). Primary endpoints: Plaque Index at 6 months, Gingival Index at 6 months and 8 more. Started Feb 2021; status: completed.

02

Drugs

melatonin
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT05870358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05870358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call